AAM taps Joanne Duncan as COODuncan will be responsible for leading and managing implementation of a more comprehensive member recruitment strategy at AAM. CDC guidance: Insurers must cover HIV prevention treatment costsInsurers, which were required to stop charging out-of-pocket fees for PrEP as of Jan. 1, have 60 days to comply with the latest rules. Rolling with the punches: Generics firms innovate, expand scope to stay competitive As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive. Roundup: Recent generic launches Taking a look at some of the innovative new generics making their debut: FDA tentatively OKs Zydus Cadila’s generic Imbruvica Zydus Cadila's generic Imbruvica tablets provide a treatment for certain types of cancer. Beximco receives FDA nod for Baclofen Baclofen had a market value of more than $110 million in 2020, according to IQVIA. Nexus debuts potassium chloride in water for injection Potassium chloride injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. Intas, Meiji and Dong-A ST to commercialize Stelara biosimilar Biosimilar ustekinumab will provide a treatment of autoimmune and inflammatory diseases such as plaque psoriasis, Crohn's disease and ulcerative colitis. Aurobindo’s generic Adalat CC gets FDA OK The market size of the product was $95 million for the 12-month period ended May 2021, according to IQVIA data. Slayback names Pete Meyers CFO Meyers most recently served as CFO of Eagle Pharmaceuticals. First Previous 102 103 104 105 106 Next Last